Exchange: NYSEMkt·Updated 07:36 PM EDT
APUS logo

APUS Apimeds Pharmaceuticals US Inc.

$2.42
$0.09
(3.59%)
Today
Closed $2.42
$0.07
(2.89%)
After Hours
Mkt Cap$3.65M
Vol24,386.00

About APUS

Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. It primarily focuses on developing innovative therapies for inflammation and pain management in knee osteoarthritis (OA) and, to a lesser extent, multiple sclerosis (MS). The company was founded on May 11, 2020 and is headquartered in Matawan, NJ.
59

Bullish Sentiment

How do you feel about APUS?

Advertisement|Remove ads.